How about a free demo of Pinnacle 21 Clinical Data Management & Automation Suite? Complete the form to book your no-obligation demo of Pinnacle 21… and see how you can increase the speed and quality of your clinical trial submission data! Trusted by leading drug developers
https://www.certara.com/thank-you-content-download-pinnacle-21/In this video, Dr. Mark Sullivan, Managing Director of Medicines Development for Global Health, explains how Certara’s model-informed drug development expertise was used to support developing moxidectin as a treatment for onchocerciasis “river blindness.” Transcript The role that Certara has played has really been a as an as a integral part of our drug development … Continued
https://www.certara.com/video/supporting-the-approval-of-a-treatment-for-a-neglected-tropical-disease/PRINCETON, N.J.— 4월 9, 2024– Certara, Inc. 글로벌 바이오시뮬레이션 선두기업(Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of 2024 after the market close on Tuesday, May 7th, 2024. Company management will host a conference call to discuss financial results at 5:00PM ET. Investors interested in listening … Continued
https://www.certara.com/pressrelease/certara-to-report-first-quarter-2024-financial-results-on-may-7th-2024-and-participate-in-the-bofa-securities-healthcare-conference/The oil and gas industry has been known for its complexity and challenging operating environments, with installations all over the world, in complicated and remote locations. According to a recent Ernst & Young survey, 92% of oil and gas companies around the world are investing in AI or plan to do so in the next … Continued
https://www.certara.com/oil-and-gas/This blog reviews the role of the endogenous biomarker, CP-1, for assessing OATP1B transporter-mediated drug-drug interactions and their clinical implications.
https://www.certara.com/blog/an-endogenous-biomarker-for-predicting-oatp1b-ddis/As the clinical research industry moves towards more efficient and automated processes, clinical metadata repositories are becoming a must. You’ve probably heard of them; sometimes they are referred to as ‘clinical MDRs’ or simply ‘CMDRs’. But you might not know exactly what they do and how they can make your clinical study build more efficient. … Continued
https://www.certara.com/blog/what-should-a-clinical-metadata-repository-do/Gain an understanding of CDISC SEND dataset creation challenges impacting the biopharma industry, and how these factors could delay regulatory submissions and strategic initiatives.
https://www.certara.com/blog/whats-driving-the-increased-demand-for-send-dataset-services/Scientists in drug discovery often spend excessive time managing research data instead of concentrating on identifying the most promising compounds for new drugs. The right technology streamlines the drug discovery process, providing a seamless workflow for data-driven design, analysis, and research tracking of small molecules. In this webinar, experts from Certara and Chemaxon will guide … Continued
https://www.certara.com/webinar/closing-the-loop-how-to-improve-the-management-of-your-design-make-test-analyze-cycle/Transcript: Did you know that eighty percent of life sciences data is unstructured? This data is messy, difficult to search, often resides in silos. Having unstructured data means that you could be missing valuable insights that can inform prioritizing new molecules for designing, executing, or submitting clinical trials. The proliferation of powerful AI models such … Continued
https://www.certara.com/video/certara-ai/
